Healthcare provider profile · identity verified

Heather Jean Greiling, APNP

Nurse Practitioner · WAUTOMA, WI · NPI 1861879462

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	185	58
Levothyroxine Sodium	Levothyroxine Sodium	145	40
Lisinopril	Lisinopril	131	35
Furosemide	Furosemide	112	27
Omeprazole	Omeprazole	111	35
Rosuvastatin Calcium	Rosuvastatin Calcium	110	31
Amlodipine Besylate	Amlodipine Besylate	100	31
Albuterol Sulfate Hfa	Albuterol Sulfate	98	35
Metoprolol Succinate	Metoprolol Succinate	96	27
Losartan Potassium	Losartan Potassium	95	32
Pantoprazole Sodium	Pantoprazole Sodium	95	28
Duloxetine Hcl	Duloxetine Hcl	92	25
Famotidine	Famotidine	86	25
Tizanidine Hcl	Tizanidine Hcl	83	25
Fluticasone Propionate	Fluticasone Propionate	78	27
Bupropion Xl	Bupropion Hcl	75	18
Buspirone Hcl	Buspirone Hcl	69	19
Baclofen	Baclofen	68	21
Pravastatin Sodium	Pravastatin Sodium	68	19
Sertraline Hcl	Sertraline Hcl	65	18
Allopurinol	Allopurinol	61	20
Fenofibrate	Fenofibrate Nanocrystallized	59	16
Hydrochlorothiazide	Hydrochlorothiazide	58	18
Potassium Chloride	Potassium Chloride	56	14
Gabapentin	Gabapentin	52	19
Mounjaro	Tirzepatide	51	suppressed
Pregabalin	Pregabalin	51	16
Escitalopram Oxalate	Escitalopram Oxalate	50	14
Meloxicam	Meloxicam	50	19
Trazodone Hcl	Trazodone Hcl	49	15
Simvastatin	Simvastatin	48	12
Metformin Hcl Er	Metformin Hcl	46	15
Alprazolam	Alprazolam	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	40	11
Lorazepam	Lorazepam	39	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	32
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Prednisone	Prednisone	37	32
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	14
Amitriptyline Hcl	Amitriptyline Hcl	32	11
Eliquis	Apixaban	32	suppressed
Carvedilol	Carvedilol	31	suppressed
Clonazepam	Clonazepam	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Metformin Hcl	Metformin Hcl	31	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	15
Ezetimibe	Ezetimibe	29	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	28	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	28	24
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Methylprednisolone	Methylprednisolone	28	23
Montelukast Sodium	Montelukast Sodium	28	suppressed
Oxcarbazepine	Oxcarbazepine	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Atenolol	Atenolol	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	14
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Glipizide	Glipizide	24	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	24	suppressed
Estradiol	Estradiol	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Fluconazole	Fluconazole	22	16
Ozempic	Semaglutide	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Nystatin	Nystatin	21	18
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Diazepam	Diazepam	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Azithromycin	Azithromycin	17	12
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Temazepam	Temazepam	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Glyburide	Glyburide	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Mupirocin	Mupirocin	14	12
Topiramate	Topiramate	14	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Verapamil Hcl	Verapamil Hcl	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error